Methyl 3-fluoro-[1,1'-biphenyl]-2-carboxylate, 95%, 1g

N-(2-Hydroxyethyl)-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzamide, 96%, 250mg

Methyl Trifluoromethanesulfonate>98.0%(GC)25g

1-(3-(Methylsulfonyl)phenyl)piperazine, 95.0%, 250mg

4-Methyl-N-(2-methylcyclopentyl)aniline, 95%, 1g

N-(2-Chloropyrimidin-4-yl)-N,2,3-trimethyl-2H-indazol-6-amine, 95.0%, 25g

(4-(Methoxycarbonyl)-3-(trifluoromethyl)phenyl)boronic acid, 95+%, 5g

1-(3,5-Dimethyl-phenyl)-ethylamine, 5g

2-Methylcyclohexanol (cis- and trans- mixture)>98.0%(GC)500mL

6-BROMO-7-HYDROXY-2,2-DIMETHYL-BENZO[1,3]DIOXIN-4-ONE, 97%, 250mg

(S)-5-Hydroxypiperidin-2-one, 95.0%, 100mg

(2-{[3-(3-methoxyphenyl)[1,2,4]triazolo[4,3-b]pyridazin-6-yl]oxy}ethyl)amine, 95.0%, 500mg

3,4-DIHYDRO-6-[[4-[[[3-(METHYLSULFONYL)PHENYL]METHYL]AMINO]-5-(TRIFLUOROMETHYL)-PYRIMIDIN-2-YL]AMINO]-2(1H)-QUINOLINONE, 98%, 1mg